u/piotr_nascimento

Week 35 on Mounjaro and 11kg down. The appetite reduction feels different from sema in ways I do not have words for yet.

dual agonism is SURPASS, do not generalise from semaglutide

Switched from sema at 7.5mg to tirz at 15mg. Different drugs, cannot compare the doses directly.

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

stalled on sema, tried tirz, and the curves were actually different shapes

below-spec results get logged, not dismissed

That is net peptide content, not purity. Different number, different meaning.

Which VendorInvestigate service and what method did they use?

declared value is customs, impacts duty

stalled on sema, tried tirz, and the curves were actually different shapes

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

dual agonism is Mounjaro, do not generalise from semaglutide

inter-lab variance is real, 14 points is inside normal

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

Respectfully this is a sample of one presented as a finding.

Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.

Cosigning. The GIP contribution is real and the side effects are not simply scaled versions.

multiple batches from SGN show a spread, that is the data

Zepbound and Mounjaro are literally the same drug, the name is the only difference